Table 1.
Lenograstim | Biosimilar filgrastim | Filgrastim | p value | |
---|---|---|---|---|
Number of donors in the group | 121 | 85 | 107 | |
Median age (interquartile range, years) | 29 (23–34) | 26 (22–33) | 29 (24–35.5) | 0.251 |
BMI (interquartile range) | 24.5 (22.1–26.7) | 24.2 (21.5–26.2) | 25.6 (22.7–28.4) | 0.018 |
Gender | 71 males/50 females | 60 males/25 females | 70males/37 females | 0.107 |
Median weight of the donor (interquartile range, kg) | 74 (63.5–85) | 82 (63.5–85) | 74 (69–90) | 0.0262 |
Mean daily dose of G-CSF (interquartile range, μg/kg of donor) | 9.1 (8.3–9.9) | 9.8 (9.0–10.4) | 9.3 (8.7–10.0) | <0.001 |